Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received October 30, 2011
- Accepted after revision November 22, 2011
- Published online September 10, 2012.
Article Versions
- Latest version (March 22, 2012 - 07:33).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2012 by American Journal of Neuroradiology Indicates open access to non-subscribers at www.ajnr.org
Author Information
- aFrom the Departments of Biostatistics (R.T.S., J.G., C.C., D.S.R.)
- bNeurology (F.J.M.), Johns Hopkins University, Baltimore, Maryland
- cNational Institute of Neurological Disorders and Stroke (R.T.S., D.S.R.), Bethesda, Maryland
- Please address correspondence to Russell T. Shinohara, MSc, Department of Biostatistics, Johns Hopkins University, Baltimore, MD 21205; e-mail: taki.shinohara{at}gmail.com
Altmetrics
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Gd contrast administration is dispensable in patients with MS without new T2 lesions on follow-up MRI
- Magnetic Susceptibility from Quantitative Susceptibility Mapping Can Differentiate New Enhancing from Nonenhancing Multiple Sclerosis Lesions without Gadolinium Injection
- Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation
- Quantitative MRI for Analysis of Active Multiple Sclerosis Lesions without Gadolinium-Based Contrast Agent